海正药业(600267.SH)子公司获得新兽药注册证书

Core Viewpoint - Haizheng Pharmaceutical's subsidiary, Zhejiang Haizheng Animal Health Products Co., has received approval for a new veterinary drug, Methylprednisolone Tablets (for dogs), marking a significant step in the company's strategic expansion in the veterinary medicine sector [1] Group 1 - The new veterinary drug product has been granted a Class V New Veterinary Drug Registration Certificate by the Ministry of Agriculture and Rural Affairs of the People's Republic of China [1] - The approval indicates that the product complies with the relevant regulations of the Veterinary Drug Administration and the Veterinary Drug Registration Measures [1] - This development is expected to enhance the company's market competitiveness in the veterinary medicine segment [1]